Skip to main content

Correction: The Board of Directors of Ortivus AB withdraws the proposal to the Annual General Meeting on 8 May 2025 regarding authorisation for the Board to issue shares, etc.

2025-04-11 10:35

The correction concerns classification as Regulatory solely in accordance with listing requirements.

The Board of Directors of Ortivus AB has resolved to withdraw its proposal that the Board be granted authorisation by the Annual General Meeting to issue class B shares, etc. The proposal is withdrawn in its entirety.

Furthermore, the Board has decided to make a minor adjustment to the proposed amendment to the Articles of Association concerning the number of class A shares that may be issued.

Previous wording
“Shares may be either class A shares or class B shares. Class A shares may be issued in a number not exceeding 5,120,000 and class B shares in a number not exceeding 160,000,000.”

Revised proposed wording
“Shares may be either class A shares or class B shares. Class A shares may be issued in a number not exceeding 6,000,000 and class B shares in a number not exceeding 160,000,000.”

In all other respects, the Board’s proposal regarding the amendment to the Articles of Association remains unchanged.

The Annual General Meeting will be held at Ortivus’ office in Danderyd on 8 May 2025 at 15:00.

Get in touch

Empower your team with smarter tools

Join leading healthcare organisations that have already improved patient outcomes and reduced costs with Ortivus’ innovative out-of-hospital solutions.

Get contacted

Fill in the form and one of our sales representatives will contact you as soon as possible.

Required